Nathan Papa

13PUBLICATIONS
56CO-AUTHORS
AcceleratorsPredictive and prognostic markersRadiation therapyData qualityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 07, 2025
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis.

David C Chen, Siyu Huang, Nathan Papa

|Sep 12, 2024
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

Matthew J Roberts, Nathan Papa, Hans Veerman

|Aug 21, 2023
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.

Matthew J Roberts, Ciara Conduit, Ian D Davis

|Oct 17, 2022
Development of binational radiation therapy quality indicator reports for prostate cancer treatment using registry data.

Edward Chmiel, Marie Pase, Melanie Evans

|Mar 17, 2022
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.

Matthew J Roberts, Andrew Morton, Nathan Papa

|Jan 20, 2022
Knowledge and insights from a maturing international clinical quality registry.

Fanny Sampurno, Christoph Kowalski, Sarah E Connor

Pageof 3

Frequent Collaborators

6 joint publications

Matthew John Roberts

3 joint publications

Louise Emmett

3 joint publications

Damien M Bolton

3 joint publications

Nathan Lawrentschuk